http://hdl.handle.net/1765/3302

Human peripheral blood lymphocytes from recently vaccinated individuals produce both type-specific and intertypic cross-reacting neutralizing antibody on in vitro stimulation with one type of poliovirus.


Article
volume 35, issue 5 pp 3094-3101.
Related Files
asset icon
(eur_osterhaus_9137.pdf, 0.9MB)

An in vitro system of poliovirus-specific antibody production by peripheral blood B cells on stimulation by the virus has been developed. Virus-neutralizing antibodies in culture supernatant fluids, or virus-specific antibody-secreting cells (ASC) were detected by microneutralization assay and ELISA-SPOT test, respectively. After booster immunization with polio vaccine, anti-poliovirus-neutralizing ASC were present in circulation. This response was measurable between 5 and 12 days after booster vaccination. At between 12 and 90 days, another subset of B cells was found in peripheral blood that only produced poliovirus-specific neutralizing antibody after in vitro antigenic stimulation. The in vitro virus-induced response required B cells, monocytes, and T4+ (T helper) cells, and was shown to result from de novo protein synthesis. The anti-poliovirus-neutralizing response in vitro could be dissected in a type-specific and intertypic cross-reactive response by using various antigen concentrations for in vitro stimulation. Evidence was obtained by absorption studies for the existence of intertypic cross-reactive neutralization-inducing epitopes.



Keywords


Automatically Extracted Terms
  • antibody
  • response
  • polioviru
  • virus
  • neutralizing
  • culture
  • antigen
  • type 3
  • fluid
  • production
  • study
  • immunization
  • concentration
  • blood
  • b cells
  • type-specific
  • t 37 c
  • poliovirus-specific
  • donor
  • vaccine


Bookmark with: